HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ana P Berbegall Selected Research
Ana P Berbegall Research Topics
Disease
13
Neuroblastoma
01/2022 - 01/2013
8
Neoplasms (Cancer)
10/2020 - 01/2013
2
Chromosome Aberrations (Chromosome Abnormalities)
06/2014 - 01/2013
1
Thalassemia
06/2014
1
Intellectual Disability (Idiocy)
06/2014
Drug/Important Bio-Agent (IBA)
3
Glycosaminoglycans
IBA
05/2018 - 02/2014
2
Biomarkers (Surrogate Marker)
IBA
12/2018 - 01/2016
1
abemaciclib
IBA
01/2022
1
ribociclib
IBA
01/2022
1
nutlin 3
IBA
01/2022
1
Glycoproteins (Glycoprotein)
IBA
10/2020
1
Hydrogels
IBA
10/2020
1
Vitronectin
IBA
10/2020
1
MicroRNAs (MicroRNA)
IBA
12/2018
1
Circulating MicroRNA
IBA
12/2018
1
Indicators and Reagents (Reagents)
IBA
05/2018
1
Glycogen Synthase Kinase 3
IBA
01/2018
1
Glycogen Synthase (Synthase I)
IBA
01/2018
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2018
1
Collagen Type I (Type I Collagen)
IBA
01/2016
1
Reticulin (Reticular Fiber)
IBA
01/2016
1
Chromogranin A
IBA
03/2015
1
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
IBA
03/2015
1
Synaptophysin
IBA
03/2015
1
Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
IBA
03/2015
1
DNA (Deoxyribonucleic Acid)
IBA
06/2014
1
X-linked Nuclear Protein
IBA
06/2014
1
Genetic Markers (Genetic Marker)
IBA
01/2013
Therapy/Procedure
2
Therapeutics
05/2018 - 02/2014
1
Drug Therapy (Chemotherapy)
08/2019
1
Aftercare (After-Treatment)
08/2019
1
Radiotherapy
01/2014
1
Ligation
01/2013